Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancer

Barbara A Pockaj, Gargi D. Basu, Latha B. Pathangey, Richard J. Gray, Jose L. Hernandez, Sandra J Gendler, Pinku Mukherjee

Research output: Contribution to journalArticle

138 Citations (Scopus)

Abstract

Background: In several neoplastic diseases, including breast cancer, immunosuppression correlates with disease stage, progression, and outcome. Thus, thorough analysis of immune parameters in breast cancer patients may be beneficial in designing effective anticancer immune-based therapies. Methods: We investigated dendritic cell and T-cell function in breast cancer patients at various stages of the disease and in age-matched controls. We also evaluated cyclooxygenase-2 (COX-2) expression and prostaglandin E2 (PGE2) levels within the tumor milieu and in the circulation. Results: T cells from cancer patients showed decreased proliferation in response to CD3 antibody stimulation. Analysis of T-cell helper type 1 and 2 cytokines revealed reduced levels of interferon-γ, tumor necrosis factor-α, interleukin (IL)-12, and IL-2 and increased levels of IL-10 and IL-4. Dendritic cells from these patients showed significantly reduced expression of co-stimulatory molecules (B7 and CD40) and demonstrated reduced phagocytic ability, reduced antigen presentation to T cells, and reduced ability to mature in response to lipopolysaccharide. Data revealed increased synthesis of PGE2, an immune suppressor, along with increased expression of COX-2, a key regulator of PGE2 synthesis. Conclusions: COX-2-induced PGE2 may contribute to immunosuppression and may directly block antitumor immunity while promoting tumor growth, providing us with the rationale for using COX-2 inhibition combined with immunotherapy.

Original languageEnglish (US)
Pages (from-to)328-339
Number of pages12
JournalAnnals of Surgical Oncology
Volume11
Issue number3
DOIs
StatePublished - 2004

Fingerprint

Cyclooxygenase 2
Dinoprostone
Dendritic Cells
Breast Neoplasms
T-Lymphocytes
Immunosuppression
B7 Antigens
Neoplasms
Th2 Cells
Th1 Cells
Antigen Presentation
Interleukin-12
Interleukin-4
Interleukin-10
Immunotherapy
Interferons
Interleukin-2
Lipopolysaccharides
Disease Progression
Immunity

Keywords

  • Breast cancer
  • Cyclooxygenase-2
  • Dendritic cells
  • Prostaglandin E
  • T cells

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancer. / Pockaj, Barbara A; Basu, Gargi D.; Pathangey, Latha B.; Gray, Richard J.; Hernandez, Jose L.; Gendler, Sandra J; Mukherjee, Pinku.

In: Annals of Surgical Oncology, Vol. 11, No. 3, 2004, p. 328-339.

Research output: Contribution to journalArticle

Pockaj, Barbara A ; Basu, Gargi D. ; Pathangey, Latha B. ; Gray, Richard J. ; Hernandez, Jose L. ; Gendler, Sandra J ; Mukherjee, Pinku. / Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancer. In: Annals of Surgical Oncology. 2004 ; Vol. 11, No. 3. pp. 328-339.
@article{a3d5445d995c47d898d9ad3057bc9f63,
title = "Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancer",
abstract = "Background: In several neoplastic diseases, including breast cancer, immunosuppression correlates with disease stage, progression, and outcome. Thus, thorough analysis of immune parameters in breast cancer patients may be beneficial in designing effective anticancer immune-based therapies. Methods: We investigated dendritic cell and T-cell function in breast cancer patients at various stages of the disease and in age-matched controls. We also evaluated cyclooxygenase-2 (COX-2) expression and prostaglandin E2 (PGE2) levels within the tumor milieu and in the circulation. Results: T cells from cancer patients showed decreased proliferation in response to CD3 antibody stimulation. Analysis of T-cell helper type 1 and 2 cytokines revealed reduced levels of interferon-γ, tumor necrosis factor-α, interleukin (IL)-12, and IL-2 and increased levels of IL-10 and IL-4. Dendritic cells from these patients showed significantly reduced expression of co-stimulatory molecules (B7 and CD40) and demonstrated reduced phagocytic ability, reduced antigen presentation to T cells, and reduced ability to mature in response to lipopolysaccharide. Data revealed increased synthesis of PGE2, an immune suppressor, along with increased expression of COX-2, a key regulator of PGE2 synthesis. Conclusions: COX-2-induced PGE2 may contribute to immunosuppression and may directly block antitumor immunity while promoting tumor growth, providing us with the rationale for using COX-2 inhibition combined with immunotherapy.",
keywords = "Breast cancer, Cyclooxygenase-2, Dendritic cells, Prostaglandin E, T cells",
author = "Pockaj, {Barbara A} and Basu, {Gargi D.} and Pathangey, {Latha B.} and Gray, {Richard J.} and Hernandez, {Jose L.} and Gendler, {Sandra J} and Pinku Mukherjee",
year = "2004",
doi = "10.1245/ASO.2004.05.027",
language = "English (US)",
volume = "11",
pages = "328--339",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancer

AU - Pockaj, Barbara A

AU - Basu, Gargi D.

AU - Pathangey, Latha B.

AU - Gray, Richard J.

AU - Hernandez, Jose L.

AU - Gendler, Sandra J

AU - Mukherjee, Pinku

PY - 2004

Y1 - 2004

N2 - Background: In several neoplastic diseases, including breast cancer, immunosuppression correlates with disease stage, progression, and outcome. Thus, thorough analysis of immune parameters in breast cancer patients may be beneficial in designing effective anticancer immune-based therapies. Methods: We investigated dendritic cell and T-cell function in breast cancer patients at various stages of the disease and in age-matched controls. We also evaluated cyclooxygenase-2 (COX-2) expression and prostaglandin E2 (PGE2) levels within the tumor milieu and in the circulation. Results: T cells from cancer patients showed decreased proliferation in response to CD3 antibody stimulation. Analysis of T-cell helper type 1 and 2 cytokines revealed reduced levels of interferon-γ, tumor necrosis factor-α, interleukin (IL)-12, and IL-2 and increased levels of IL-10 and IL-4. Dendritic cells from these patients showed significantly reduced expression of co-stimulatory molecules (B7 and CD40) and demonstrated reduced phagocytic ability, reduced antigen presentation to T cells, and reduced ability to mature in response to lipopolysaccharide. Data revealed increased synthesis of PGE2, an immune suppressor, along with increased expression of COX-2, a key regulator of PGE2 synthesis. Conclusions: COX-2-induced PGE2 may contribute to immunosuppression and may directly block antitumor immunity while promoting tumor growth, providing us with the rationale for using COX-2 inhibition combined with immunotherapy.

AB - Background: In several neoplastic diseases, including breast cancer, immunosuppression correlates with disease stage, progression, and outcome. Thus, thorough analysis of immune parameters in breast cancer patients may be beneficial in designing effective anticancer immune-based therapies. Methods: We investigated dendritic cell and T-cell function in breast cancer patients at various stages of the disease and in age-matched controls. We also evaluated cyclooxygenase-2 (COX-2) expression and prostaglandin E2 (PGE2) levels within the tumor milieu and in the circulation. Results: T cells from cancer patients showed decreased proliferation in response to CD3 antibody stimulation. Analysis of T-cell helper type 1 and 2 cytokines revealed reduced levels of interferon-γ, tumor necrosis factor-α, interleukin (IL)-12, and IL-2 and increased levels of IL-10 and IL-4. Dendritic cells from these patients showed significantly reduced expression of co-stimulatory molecules (B7 and CD40) and demonstrated reduced phagocytic ability, reduced antigen presentation to T cells, and reduced ability to mature in response to lipopolysaccharide. Data revealed increased synthesis of PGE2, an immune suppressor, along with increased expression of COX-2, a key regulator of PGE2 synthesis. Conclusions: COX-2-induced PGE2 may contribute to immunosuppression and may directly block antitumor immunity while promoting tumor growth, providing us with the rationale for using COX-2 inhibition combined with immunotherapy.

KW - Breast cancer

KW - Cyclooxygenase-2

KW - Dendritic cells

KW - Prostaglandin E

KW - T cells

UR - http://www.scopus.com/inward/record.url?scp=2442696835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442696835&partnerID=8YFLogxK

U2 - 10.1245/ASO.2004.05.027

DO - 10.1245/ASO.2004.05.027

M3 - Article

C2 - 14993030

AN - SCOPUS:2442696835

VL - 11

SP - 328

EP - 339

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 3

ER -